Vaxcyte shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Vaxcyte
Tip: Access up to 7 years of quarterly data
All positions including Vaxcyte held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Vaxcyte by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $5.1M | 82k | 62.80 |
2023-09-30 | $3.8M | 75k | 50.98 |
2023-06-30 | $2.1M | 56k | 37.48 |
2023-03-31 | $2.1M | 56k | 37.48 |
2022-12-31 | $2.5M | 52k | 47.95 |
2022-09-30 | $831k | 35k | 24.00 |
2022-06-30 | $225k | 10k | 21.76 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas